The DOI matches its Crossref record; 180 of the 181 references it cites were found in a registry or an index.
Diabetic Neuropathy
Abstract
Diabetic neuropathy (DN) is the most common and troublesome complication of diabetes mellitus, leading to the greatest morbidity and mortality and resulting in a huge economic burden for diabetes care. The clinical assessment of diabetic peripheral neuropathy and its treatment options are multifactorial. Patients with DN should be screened for autonomic neuropathy, as there is a high degree of coexistence of the two complications. A review of the clinical assessment and treatment algorithms for diabetic neuropathy, painful neuropathy, and autonomic dysfunction is provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The true prevalence is unclear but it varies from 10 to 90% in diabetics, according to the different standards and approaches used to define diabetic neuropathy (107).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [107]
In the citing paper
“It has been reported that neuropathy is associated with a 1.7-fold increase in the risk of amputation, and even higher when coupled with other problems (107).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [107]
Citations
Cites
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Giniès, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,834
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Self-citationFreynhagen, R., Baron, R., Gockel, U., & Tölle, T. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132488 · Cited by 2,280
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citation
Flagged first, then by citations
1 of the 181 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Barada, 1999, Proximal diabetic neuropathy—response to immunotherapy, Diabetes, 48, A148
- Vinik, 1999, Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF), Diabetes, 48, A54
- Bastyr, 2002, Neuropathy Total symptom Score-6 Questionnaire (NTSS-6) is a valid instrument for assessing the positive symptoms of diabetic peripheral neuropathy (DPN), Diabetes, 51, A199
- Ziegler, 2011, Antioxidant treatment with alpha-lipoic acid in diabetic polyneuropathy: a 4-year randomized double-blind trial (NATHAN 1), Diabetologia, 50, S63
Cited by
Sorted by citations
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationDiabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, R., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 537
Self-citationDiabetic neuropathic pain: Physiopathology and treatment
Schreiber, A. K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.432 · Cited by 484
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, O. C., Steen, A., & Covașă, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 448
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 306
Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
Serhiyenko, V. A., & Serhiyenko, A. A. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i1.1 · Cited by 263
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B. T., Wang, Y., Lan, H. H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 320
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Autonomic Neuropathy in Diabetes Mellitus
Verrotti, A., Prezioso, G., Scattoni, R., & Chiarelli, F. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00205 · Cited by 187
Timar, B., Timar, R. Z., Gaiţă, L., Oancea, C. I., Levai, C., & Lungeanu, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154654 · Cited by 168
Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora, E., Smith, E., Donohoe, C., & Hertz, D. L. (2016) · PubMed Central · Cited by 157
Gylfadottir, S. S., Christensen, D. H., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Itani, M., Khan, K. S., Kristensen, A. G., Nielsen, J. S., Sindrup, S. H., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001744 · Cited by 151
Fuchs, D., Dupon, P. P., Schaap, L. S., & Draijer, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0487-1 · Cited by 123
Demaré, S., Kothari, A., Calcutt, N. A., & Fernyhough, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1847645 · Cited by 117
Vinik, E. J., Vinik, A. I., Paulson, J. F., Merkies, I. S. J., Packman, J., Grogan, D. R., & Coelho, T. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12059 · Cited by 114
Self-citationDiabetic Sensory and Motor Neuropathy
Vinik, A. I. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503948 · Cited by 113
Self-citationTreating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
Song, S. O., He, K., Narla, R. R., Kang, H. G., Ryu, H. U., & Boyko, E. J. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0256 · Cited by 106
Vinik, A., Rosenstock, J., Sharma, U., Feins, K., Hsu, C., & Merante, D. (2014) · Diabetes Care · doi:10.2337/dc14-1044 · Cited by 100
Self-citationYang, Q., Zhang, Y., Zhang, X., & Li, X. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.02.19 · Cited by 102
Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Alam, M., Ali, S., Ahmed, S., Elasbali, A. M., Adnan, M., Islam, A., Hassan, M. I., & Yadav, D. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212162 · Cited by 91
L‐serine: a neglected amino acid with a potential therapeutic role in diabetes
Holm, L. J., & Buschard, K. (2019) · Apmis · doi:10.1111/apm.12987 · Cited by 90
Truini, A., Spallone, V., Morganti, R., Tamburin, S., Zanette, G., Schenone, A., De Michelis, C., Tugnoli, V., Simioni, V., Manganelli, F., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001378 · Cited by 85
Falls Risk in Older Adults with Type 2 Diabetes
Vinik, A. I., Vinik, E. J., Colberg, S. R., & Morrison, S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.09.002 · Cited by 87
Self-citationEmerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes
Pandey, V. K., Mathur, A., & Kakkar, P. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.041 · Cited by 76
Double‐blind, placebo‐controlled study of HGF gene therapy in diabetic neuropathy
Kessler, J. A., Smith, A. G., Cha, B., Choi, S. H., Wymer, J., Shaibani, A. I., Ajroud‐Driss, S., Vinik, A. I., & VM202 DPN‐II Study Group (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.186 · Cited by 72
Self-citationLatronico, N., Nattino, G., Guarneri, B., Fagoni, N., Amantini, A., Bertolini, G., & and GiVITI Study Investigators (2014) · F1000Research · doi:10.12688/f1000research.3933.1 · Cited by 70
Kessler, J. A., Shaibani, A. I., Sang, C. N.-M., Christiansen, M. P., Kudrow, D., Vinik, A. I., Shin, N., & the VM202 study group (2021) · Clinical and Translational Science · doi:10.1111/cts.12977 · Cited by 69
Self-citationDiagnosis and management of sensory polyneuropathy
Gwathmey, K. G., & Pearson, K. (2019) · BMJ · doi:10.1136/bmj.l1108 · Cited by 76
Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors
Lee, S. R., An, E. J., Kim, J., & Bae, Y. S. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.188 · Cited by 64
Diabetic Peripheral Neuropathy: Diagnosis and Treatment
Røikjer, J., Mørch, C. D., & Ejskjær, N. (2020) · Current Drug Safety · doi:10.2174/1574886315666200731173113 · Cited by 68
Latronico, N., Nattino, G., Guarneri, B., Fagoni, N., Amantini, A., Bertolini, G., & and GiVITI Study Investigators (2014) · F1000Research · doi:10.12688/f1000research.3933.3 · Cited by 81
Morrison, S., Simmons, R., Colberg, S. R., Parson, H. K., & Vinik, A. I. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.11.004 · Cited by 56
Self-citationWorthington, A., Alam, U., Themistocleous, A. C., Calcutt, N. A., & Marshall, A. G. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.03.020 · Cited by 56
The effects of metformin in the treatment of osteoarthritis: Current perspectives
Song, Y., Wu, Z., & Zhao, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952560 · Cited by 55
Tan, D., Tseng, H. H. L., Zhong, Z., Wang, S., Vong, C. T., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231910988 · Cited by 55
Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
Preston, F., Riley, D. R. J., Azmi, S., & Alam, U. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s370050 · Cited by 63
Atmaca, A. A., Ketenci, A., Şahin, İ., Şengün, İ. Ş., Öner, R. İ., Tilki, H. E., Adaş, M., Soyleli, H., & Demir, T. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1380929 · Cited by 62
Brown, J. J., Pribesh, S. L., Baskette, K. G., Vinik, A. I., & Colberg, S. R. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1467213 · Cited by 50
Self-citationMeyer‐Hamme, G., Friedemann, T., Greten, H. J., Gerloff, C. P., & Schröder, S. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13130 · Cited by 51
The impact of type 1 diabetes and diabetic polyneuropathy on muscle strength and fatigability
Orlando, G., Balducci, S., Bazzucchi, I., Pugliese, G., & Sacchetti, M. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0979-9 · Cited by 50
Rasoulian, B., Hajializadeh, Z., Esmaeili‐Mahani, S., Rashidipour, M., Fatemi, I., & Kaeidi, A. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-018-0620-x · Cited by 49
Genetic and Epigenomic Modifiers of Diabetic Neuropathy
Janković, M. Z., Novaković, I. V., Nikolić, D., Maksić, J., Brankovic, S., Petronić, I., Ćirović, D., Dučić, S., Grajić, M., & Bogićević, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094887 · Cited by 48
liu, F., Ma, F., Kong, G., Wu, K., Deng, Z., & Wang, H. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9923-9 · Cited by 48
Melese, H., Alamer, A., Temesgen, M. H., & Kahsay, G. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s261175 · Cited by 46
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
Kaku, M. C., Vinik, A. I., & Simpson, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0609-2 · Cited by 48
Self-citationMicrovascular complications among patients with diabetes: An emerging health problem in Saudi Arabia
Robert, A. A., & Dawish, M. A. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118820714 · Cited by 47
Vereșiu, I. A., Bondor, C. I., Florea, B., Vinik, E. J., Vinik, A. I., & Gavan, N. A. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.04.001 · Cited by 45
Self-citationWu, C., Wang, G., Zhao, Y., Hao, W., Zhao, L., Zhang, X., Cao, J., Wang, S., Chen, W., Chan, Q., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4698-3 · Cited by 44
Biomarkers in diabetic neuropathy
Adki, K. M., & Kulkarni, Y. A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1837183 · Cited by 42
Moura-Tonello, S. C. G., Porta, A., Marchi, A., Fagundes, A. D. A., Francisco, C. D. O., Rehder‐Santos, P., Milan‐Mattos, J. C., Simões, R. P., Góis, M. D. O., & Catai, A. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148903 · Cited by 43
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?
Serhiyenko, V. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.245 · Cited by 42
Toxic and Nutritional Optic Neuropathies—An Updated Mini-Review
Baj, J., Forma, A., Kobak, J., Tyczyńska, M., Dudek, I., Maani, A., Teresiński, G., Buszewicz, G., Januszewski, J., & Flieger, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053092 · Cited by 42
Corriero, A., Giglio, M., Inchingolo, F., Moschetta, A., Varrassi, G., & Puntillo, F. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00565-3 · Cited by 48
Abrams, R. M. C., Pedowitz, E., & Simpson, D. M. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1874920 · Cited by 40
Novák, P. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.09.027 · Cited by 41
Naringin Attenuates the Diabetic Neuropathy in STZ-Induced Type 2 Diabetic Wistar Rats
Ahmad, M. F., Naseem, N., Rahman, I., Imam, N., Younus, H., Pandey, S. K., & Siddiqui, W. A. (2022) · Life · doi:10.3390/life12122111 · Cited by 46
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Fan, G., Gong, T., Lin, Y., Wang, J., Sun, L., Wei, H., Yang, X., Liu, Z., Li, X., Zhao, L., et al. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09338-6 · Cited by 38
Diabetes-Related Microvascular Complications – A Practical Approach
Mishriky, B. M., Cummings, D. M., & Powell, J. R. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.008 · Cited by 40
Heart Rate Variability for the Early Detection of Cardiac Autonomic Dysfunction in Type 1 Diabetes
Castiglioni, P., Faini, A., Nys, A., Busser, R. D., Scherrenberg, M., Baldussu, E., Parati, G., & Dendale, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.937701 · Cited by 35
Tao, H., Liu, X., Tian, R., Liu, Y., Zeng, Y., Meng, X., & Zhang, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115726 · Cited by 34
Nabrdalik, K., Kwiendacz, H., Moos, J., Moos, Ł., Kulpa, J., Brzoza, Z., Stompór, T. P., Gumprecht, J., & Lip, G. Y. H. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101726 · Cited by 37
Buraczyńska, M., Buraczyńska, K., Dragan, M., & Książek, A. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8438-2 · Cited by 36
Amell, A., Roso‐Llorach, A., Palomero, L., Cuadras, D., Galván‐Femenía, I., Serra-Musach, J., Comellas, F., de Cid, R., Pujana, M. Á., & Violán, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34361-3 · Cited by 33
Sensory manifestations of diabetic neuropathies
Kazamel, M., & Dyck, P. J. (2015) · Prosthetics and Orthotics International · doi:10.1177/0309364614536764 · Cited by 36
Oxytocin provides protection against diabetic polyneuropathy in rats
Erbaş, O., Taşkıran, D., Oltulu, F., Yavaşoğlu, A., Bora, E. S., Bilge, O., Çınar, B. P., & Peker, G. (2016) · Neurological Research · doi:10.1080/01616412.2016.1249630 · Cited by 33
Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes
Lovshin, J. A., Lytvyn, Y., Lovblom, L. E., Katz, A., Boulet, G., Bjornstad, P., LAI, V. S., Cham, L., TSE, J. M., Orszag, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1809 · Cited by 33
Jamal, A., Ahmad, I., Ahamed, N. M. B., Azharuddin, M., Alam, F., & Hussain, M. E. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00476-1 · Cited by 33
The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Antibiotics · doi:10.3390/antibiotics13050392 · Cited by 33
Dioscin: Therapeutic potential for diabetes and complications
Gao, H., Wang, Z., Zhu, D., Zhao, L., & Xiao, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116051 · Cited by 32
A Comprehensive Analysis of Diabetic Complications and Advances in Management Strategies
IWASAKI, H. O., Yagyu, H., & Shimano, H. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65551 · Cited by 36
State-of-the-art pharmacotherapy for diabetic neuropathy
Azmi, S., Alam, U., Burgess, J., & Malik, R. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1812578 · Cited by 30
Ashjari, D., Karamali, N., Rajabinejad, M., Hassani, S. S., Hezarkhani, L. A., Afshari, D., Karaji, A. G., Salari, F., & Rezaiemanesh, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09178 · Cited by 32
Özuğuz, U., Oruç, S., Ulu, M. S., Demirbaş, H., Acay, A., Çoker, B., Beyazıt, B., Yaman, M., & Köken, T. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0509-6 · Cited by 31
Yorek, M. S., Obrosov, A. A., Shevalye, H., Coppey, L. J., Kardon, R. H., & Yorek, M. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.022 · Cited by 30
Clarke, J.-P. W. E., & Mearow, K. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23733 · Cited by 30
Takahashi, K., Mizukami, H., Osonoi, S., Ogasawara, S., Hara, Y., Kudoh, K., Takeuchi, Y., Sasaki, T., Daimon, M., & Yagihashi, S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105392 · Cited by 29
Patient and Disease Characteristics Associate With Sensory Testing Results in Chronic Pancreatitis
Kuhlmann, L., Olesen, S. S., Grønlund, D., Olesen, A. E., Phillips, A. E., Faghih, M., & Drewes, A. M. (2019) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000740 · Cited by 29
Prevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
Barbosa, M., Saavedra, A., Oliveira, S. C., Reis, L. D. D., Rodrigues, F., Severo, M., Sittl, R., Maier, C., & Carvalho, D. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00402 · Cited by 31
Mizukami, H., Osonoi, S., Takaku, S., Yamagishi, S., Ogasawara, S., Sango, K., Chung, S. K., & Yagihashi, S. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa168 · Cited by 28
Baxi, H., Habib, A., Hussain, M. S., Hussain, S., & Dubey, K. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00597-y · Cited by 32
Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes
Mendivil, C. O., Kattah, W., Orduz, A., Tique, C., Cárdenas, J. L., & Patiño, J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.004 · Cited by 27
Neuroprotective effects of flavonoids: endoplasmic reticulum as the target
Amiri, B., Tabrizi, M. Y., Naziri, M., Moradi, F., Arzaghi, M., Archin, I., Behaein, F., Pour, A. B., Ghannadikhosh, P., Imanparvar, S., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1348151 · Cited by 27
Hu, W., Ding, Y., Li, Q., Shi, R., & He, Y. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13244 · Cited by 25
Wang, A., Shi, X., Yu, R., Qiao, B., Yang, R., & Xu, C. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.663649 · Cited by 26
Effects of Melatonin on Diabetic Neuropathy and Retinopathy
Oliveira‐Abreu, K., Cipolla‐Neto, J., & Leal‐Cardoso, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010100 · Cited by 26
Jiang, Z., Bian, M., Wu, J., Li, D., Ding, L., & Zeng, Q. (2020) · BioMed Research International · doi:10.1155/2020/5939815 · Cited by 25
Zhao, L., Chen, H., Zeng, Y., YANG, K. Y., Zhang, R., Li, Z., Yang, T., & Ruan, H.-L. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0739 · Cited by 27
Moon, S., Kim, C. H., Kang, S. M., Kim, E. S., Oh, T. J., Yun, J., Cho, H., Kim, D. J., & Park, T. S. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0120 · Cited by 25
Sun, Q., Zeng, J., Liu, Y., Chen, J., Zeng, Q.-C., Chen, Y., Tu, L.-L., Chen, P., Yang, F., & Zhang, M. (2020) · Aging · doi:10.18632/aging.103230 · Cited by 24
The Diabetic Foot–Pain–Depression Cycle
Brooks, B. M., Shih, C.-D., Brooks, B. M., Tower, D. E., Tran, T., Simon, J. E., & Armstrong, D. G. (2023) · Journal of the American Podiatric Medical Association · doi:10.7547/22-126 · Cited by 25
Charcot arthropathy of the diabetic foot in a sub‐Saharan tertiary hospital: a cross‐sectional study
Wanzou, J. P. V., Sekimpi, P., Komagum, J. O., Nakwagala, F. N., & Mwaka, E. (2019) · Journal of Foot and Ankle Research · doi:10.1186/s13047-019-0343-0 · Cited by 24
Fisiopatología y alteraciones clínicas de la diabetes mellitus tipo 2
Fernández, C. I. J., Pereira, Y. A. M., Chang, A. S. O., Olmedo, S. I. G., & Gaete, M. C. A. (2022) · Nova · doi:10.22490/24629448.6184 · Cited by 24
Ratan, Y., Rajput, A., Pareek, A., Pareek, A., Kaur, R., Sonia, S., Kumar, R., & Singh, G. (2024) · Biomedicines · doi:10.3390/biomedicines12071390 · Cited by 25
Kebede, S. A., Tusa, B. S., Weldesenbet, A. B., Tessema, Z. T., & Ayele, T. A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00402-4 · Cited by 23
Disease related changes in vocal parameters of patients with type 2 diabetes mellitus
Gölaç, H., Atalık, G., Türkcan, A. K., & Yılmaz, M. (2021) · Logopedics Phoniatrics Vocology · doi:10.1080/14015439.2021.1917653 · Cited by 22
The cross‐talk between RAGE and DIAPH1 in neurological complications of diabetes: A review
Zglejc‐Waszak, K., Mukherjee, K., & Juranek, J. K. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15433 · Cited by 22
Guzyk, M. M., Dyakun, K., Yanitska, L. V., Pryvrotska, I. B., Krynytska, І., Pishel, I., & Kuchmerovska, T. M. (2017) · Neurophysiology · doi:10.1007/s11062-017-9672-4 · Cited by 20
Predictive Model of Diabetic Polyneuropathy Severity Based on Vitamin D Level
Fitri, A., Sjahrir, H., Bachtiar, A., Ichwan, M., Fitri, F. I., & Rambe, A. S. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.454 · Cited by 21
Kuipers, J., Oosterhuis, J. K., Paans, W., Krijnen, W. P., Gaillard, S., Westerhuis, R., & Franssen, C. F. M. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1366-2 · Cited by 20
Metadata
- Authors
- Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H.
- Affiliations
- Eastern Virginia Medical School (US)
- Corresponding author
- Vinik, Aaron I.
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 42
- Issue
- 4
- Pages
- 747-787
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W4210977503
- Cited by
- 366
- References
- 181
- Citations by year
- 2026: 30 · 2025: 36 · 2024: 42 · 2023: 38 · 2022: 40 · 2021: 36 · 2020: 41 · 2019: 27 · 2018: 12 · 2017: 16 · 2016: 17 · 2015: 15 · 2014: 16
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology and Metabolism Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, autonomic neuropathy, diabetic neuropathic pain, autonomic dysfunction, diabetes complications, neuropathy screening, clinical evaluation
- MeSH terms
- Autonomic Nervous System Diseases, Cardiovascular Diseases, Diabetic Neuropathies, Humans, Hyperglycemia, Neuralgia, Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
